A detailed history of Exchange Traded Concepts, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 63,962 shares of NVO stock, worth $5.52 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares
63,962
Previous 45,592 40.29%
Holding current value
$5.52 Million
Previous $6.51 Million 17.03%
% of portfolio
0.18%
Previous 0.17%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$119.07 - $145.42 $2.19 Million - $2.67 Million
18,370 Added 40.29%
63,962 $7.62 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $5.59 Million - $6.7 Million
45,592 New
45,592 $6.51 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $195B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.